Travel Medicine is one branch of medicine which specializes in preventing and treating medical problems for travelers especially when they are traveling. It is undeniable that there are differences in medical knowledge between developing and developed countries when dealing with traveler’s health problems. The purpose of this study is to comprehend the characteristics and health problems of travelers who visited Sanglah General Hospital between 2017 and 2019. This is a descriptive study which used consecutive sampling in every medical record of the patients to study their health problems. Every medical record recorded the name, age, sex,  health insurance, inpatient or outpatient, and diagnosis of the patients. As many as 618 subjects’ medical record number was conducted at first with dominantly men (55.2%) and women (44.8%). The mean age of this study was 42,76 years old with the eldest age being 92 years old and the youngest being 18 years old. As many as 328 subjects (53.1%) of this study did not use health insurance and only 290 subjects (46.9%) used health insurance. The number of outpatients, which was 564 subjects (91.3%), was much more than the number of inpatients in this study. Frequent health problems that subjects suffered were malignancy (solid and hematologic) 116  subjects (18.7%), kidney problem 107 subjects (17.3%), and accident (wounds, fracture and head trauma) 44 subjects (7.1%). Descriptive study among travelers is not usually done in our hospital and this is an elementary study so that in the future there will be more study for travelers.Keywords: Travel medicine; Travel; Tourism.

BACKGROUND Anal human papillomavirus (HPV) is associated with the severity of anal cytologic abnormalities that are precancerous lesions. Knowledge of HPV type distribution in populations at risk for anal cancer is needed. This study investigated anal HPV infections and cytological abnormalities among men who have sex with men (MSM). METHODS A cross-sectional study was conducted involving 90 men aged >30 years with a history of anal sexual intercourse with men. Demographic characteristics and sexual behaviors were collected by using a self-completed questionnaire. Anal cytological results were examined, and HPV genotyping was performed by the Linear Array HPV genotyping test. Descriptive analyses of subject characteristics, prevalence, and 95% confidence intervals (CI) were performed. A chi-square test was used to determine their associations with high-risk HPV infection and cytological abnormalities. RESULTS The overall prevalence of abnormal cytology was 32% (24/75), atypical squamous cells of undetermined significance (ASCUS) 17.33 % (13/75), 14.66% (11/75) were classified as low-grade SIL (LSIL) and no participant had high-grade SIL (HSIL). Prevalence of HPV infection with normal cytology was 86.27% (44/51), ASCUS 92.30% (12/13), and LSIL 100% (11/11). The most common types of anal HPV in participants with cytological abnormalities are HPV 16, HPV 18 for high-risk HPV, and HPV 11, HPV 6 for low-risk HPV. There were no associations between the predictor variables and the abnormal cytology (p>0.05). CONCLUSION There was a high prevalence of HPV infection in MSM with abnormal anal cytology. A routine anal Pap smear program and vaccination are needed to prevent HPV infection and anal dysplasia in MSM.

Experts have speculated the potential of heparin administration as COVID-19 treatment modality, although scientific research regarding its effectivity, recommended dosage, and period are still minimal. This study aims to explore the capacity of LMWH as a medicament for COVID-19, in effort to provide scientific reference for further development of COVID-19 possible choice of treatment or medicament. A retrospective study was conducted in Udayana University Hospital, Bali, Indonesia. Data were sourced from laboratory-confirmed COVID-19 patients medical records during March 25 to July 31, 2020. Clinical, laboratory, treatment and use of LMWH data were reviewed and statistically processed.  42 patients we found Use of LMWH. The patient categorizes from moderate to severe COVID-19. 31 patients use of LMWH for prophylaxis and 11 patients use of LMWH for treatment. 7 patients were death in the hospital, and the other was survived. LMWH elevates coagulation dysfunction in COVID-19 patients. We believe that beneficial effects of LMWH as prophylaxis or treatment in COVID-19 patients.